Synthesis and cytotoxicity evaluation of 3-amino-2-hydroxypropoxygenistein derivatives. 2017

Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
Department of Organic Chemistry, China Pharmaceutical University, Nanjing 210009, China.

Soy isoflavones exhibit various biological activities, such as antioxidant, anti-tumor, anti-inflammatory, and cardiovascular protective effects. The present study was designed to investigate the effects of sixteen synthesized 3-amino-2-hydroxypropoxy genistein derivatives on cell proliferation and activation of Nrf2 (Nuclear factor erythroid 2-related factor 2)/ARE (antioxidant response elements) pathway in human cancer cell lines. Most of the tested compounds exerted greater cytotoxic activity than genistein, as measured by MTT assay. Moreover, compound 8c showed the highest ARE-luciferase reporter activity among the test compounds. It strongly promoted Nrf2 nuclear translocation and up-regulated the expression of total Nrf2 and downstream targets NQO-1 and HO-1 at protein level. The present study may provide a basis for the application of isoflavone derivatives as Nrf2/ARE pathway inducers for cancer therapy and cancer prevention.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013025 Glycine max An annual legume. The SEEDS of this plant are edible and used to produce a variety of SOY FOODS. Soy Beans,Soybeans,Bean, Soy,Beans, Soy,Soy Bean,Soybean
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051267 NF-E2-Related Factor 2 A basic-leucine zipper transcription factor that was originally described as a transcriptional regulator controlling expression of the BETA-GLOBIN gene. It may regulate the expression of a wide variety of genes that play a role in protecting cells from oxidative damage. Nfe2l2 Protein,Nuclear Factor (Erythroid-Derived 2)-Like 2 Protein,Nuclear Factor E2-Related Factor 2,NF E2 Related Factor 2,Nuclear Factor E2 Related Factor 2
D051547 Heme Oxygenase-1 A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN. Hemeoxygenase 1,Heme Oxygenase 1,Oxygenase-1, Heme

Related Publications

Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
December 2017, Acta pharmaceutica (Zagreb, Croatia),
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
April 2003, Bioorganic & medicinal chemistry,
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
April 2011, Archives of pharmacal research,
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
September 2016, Fitoterapia,
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
March 2019, Molecules (Basel, Switzerland),
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
September 2009, European journal of medicinal chemistry,
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
May 2013, Chinese journal of natural medicines,
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
August 2011, Bioorganic & medicinal chemistry letters,
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
July 1977, The Journal of organic chemistry,
Xiao-Ting Geng, and Jing-Jing Tang, and Kun-Peng Cheng, and Yuan-Tao Fu, and Rong Hu, and Jin-Rong Lu
May 2007, Archiv der Pharmazie,
Copied contents to your clipboard!